Clinical & Diagnostic
MGI Tech, SAMRC and DSTI Launch Africa’s First DNBSEQ-T7 Sequencer and 110K Human Genome Program in South Africa
MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced two historic milestones...
November 12, 2025 | News
Mabwell Secures NMPA Approval to Begin Phase II Trial of First-in-Class Anti-IL-11 Antibody for Pathological Scarring
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its novel anti‑IL‑11 monoclonal antibody...
November 12, 2025 | News
Boehringer Ingelheim’s Metalyse Gains Singapore Approval for Acute Ischaemic Stroke Treatment
Boehringer Ingelheim, one of the world’s leading research-driven pharmaceutical companies, has announced that the blood clot-dissolving medicine...
November 12, 2025 | News
OGT Launches SureSeq™ Myeloid MRD Plus NGS Panel to Enhance Detection of Residual Disease in AML
OGT announced the launch of a new next-generation sequencing (NGS) panel for Measurable Residual Disease (MRD) - the SureSeq™ Myeloid MRD Plus NGS Pa...
November 11, 2025 | News
Simcere Advances Treg-Selective IL-2 Mutant SIM0278 into Phase II Trial for Moderate-to-Severe Atopic Dermatitis
Simcere Pharmaceutical Group (2096.HK) announced that its regulatory T cells (Treg) -preferential IL-2 mutant Fc fusion protein (IL-2 mu-Fc), SIM0278,...
November 11, 2025 | News
Muna Therapeutics Doses First Subjects in Phase 1 Trial of TREM2 Agonist MNA-001 for Alzheimer’s Disease
MNA-001 has best-in-class potential based on preclinical data demonstrating ability to significantly reduce neurotoxic amyloid burden and reprogram microgl...
November 11, 2025 | News
Akeso Initiates First-in-Human Trial of Personalised mRNA Vaccine AK154 for Pancreatic Cancer
Akeso, Inc. (HKEX: 9926. HK) is pleased to announce that the first patient has been dosed in a Phase I clinical trial evaluating the personalized mRNA vacc...
November 11, 2025 | News
Eyexora Establishes Co-Headquarters in Singapore to Drive Global Ophthalmic Innovation
-Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, announced the establishment of its co-he...
November 07, 2025 | News
PolyActiva and RareSight Forge Strategic Partnership to Develop Sustained-Release Therapies for Rare Pediatric Retinal Diseases
Partnership Leverages PolyActiva’s PREZIA™ Drug Delivery Platform Technology and RareSight’s Expertise in Rare Diseases to Advance Nove...
November 07, 2025 | News
Samsung Bioepis Reaches Settlement with J&J on Stelara Biosimilar PYZCHIVA in Europe
Samsung Bioepis Co., Ltd. has signed a settlement and license agreement with Johnson & Johnson concerning the commercialization of PYZCHIVA®, a bio...
November 07, 2025 | News
CorrectSequence Therapeutics Achieves World’s First Gene-Editing Success in Hyperlipidaemia Treatment
CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy On&n...
November 07, 2025 | News
Asahi Kasei’s Nefecon Included in KDIGO 2025 Guideline for IgA Nephropathy Management
Asahi Kasei, a global provider of healthcare and pharmaceutical solutions, announced that Nefecon (marketed in the United States as TARPEYO® (budesonid...
November 06, 2025 | News
Avant Technologies and SGAustria Form Joint Venture to Pioneer Stem Cell–Based Diabetes Therapies
Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a Nevada-based corporation, and SGAustria Pte. Ltd. (SGAustria), ...
November 06, 2025 | News
Novo Nordisk Launches Wegovy® in Hong Kong to Tackle Rising Obesity Rates with Proven Long-Term Weight Management Therapy
Wegovy® (semaglutide) is a once-weekly injectable prescription medicine used in combination with a reduced calorie diet and increased physical a...
November 04, 2025 | News
Most Read
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
